A simple nomogram prediction model to identify relatively young patients with mild cognitive impairment who may progress to Alzheimer's disease
Related Experiment Video
Updated: Oct 25, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Wenhong Chen1, Songtao Li1, Yangyang Ma1
1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Aim:
Construct a clinical predictive model based on easily accessible clinical features and imaging data to identify patients 65 years of age and younger with mild cognitive impairment(MCI) who may progress to Alzheimer's disease(AD).
Methods:
From the ADNI database, patients with MCI who were less than or equal to 65 years of age and who had been followed for 6-60 months were selected.We collected demographic data, neuropsychological test scale scores, and structural magnetic images of these patients. Clinical characteristics were then screened, and VBM and SBM analyses were performed using structural nuclear magnetic images to obtain imaging histology characteristics. Finally, predictive models were constructed combining the clinical and imaging histology characteristics.
Results:
The constructed nomogram has a cross-validated AUC of 0.872 in the training set and 0.867 in the verification set, and the calibration curve fits well.We also provide an online model-based forecasting tool.
Conclusion:
The model has good performance and uses convenience,it should be able to provide assistance in clinical work to screen relatively young MCI patients who may progress to AD.
Insights
A new predictive model identifies younger patients with mild cognitive impairment (MCI) who may develop Alzheimer's disease (AD). This tool combines clinical data and brain imaging for early screening and intervention.
Area of Science:
- Neurology
- Neuroimaging
- Geriatrics
Background:
- Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD).
- Early identification of MCI patients at high risk for AD progression is crucial for timely intervention.
- Predictive models can aid clinicians in stratifying risk within younger MCI populations.
Purpose of the Study:
- To develop a clinical predictive model for identifying MCI patients (≤65 years) likely to progress to AD.
- To integrate easily accessible clinical features with structural neuroimaging data for enhanced prediction.
- To validate the model's performance in a distinct patient cohort.
Main Methods:
- Utilized data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.
- Selected MCI patients ≤65 years with 6-60 months follow-up.
- Extracted demographic, neuropsychological, and structural MRI data.
- Performed voxel-based morphometry (VBM) and surface-based morphometry (SBM) analyses.
- Constructed predictive models combining clinical and imaging features.
Main Results:
- The developed nomogram achieved a cross-validated AUC of 0.872 (training set) and 0.867 (verification set).
- Calibration curves demonstrated good model fit.
- An online forecasting tool based on the model is available.
Conclusions:
- The predictive model demonstrates strong performance and ease of use.
- This tool can assist clinicians in screening younger MCI patients at risk of progressing to AD.
- Facilitates earlier detection and potential therapeutic strategies for at-risk individuals.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment